Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALB | P02768 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4745588 | 0.79 | PDE3A (0.45) | ALB | |
| SCHEMBL5976411 | 0.78 | PDE4D (0.35) | ALB | |
| SCHEMBL28976992 | 0.73 | PDE4D (0.37) | ALB | |
| SCHEMBL598529 | 0.69 | ALB (0.36) | ALB | |
| SCHEMBL9224814 | 0.69 | ALB (0.33) | ALB | |
| SCHEMBL22261833 | 0.69 | ALB (0.33) | ALB | |
| SCHEMBL3437075 | 0.68 | ABL1 (0.46) | ALB | |
| SCHEMBL31488686 | 0.68 | ABL1 (0.46) | ALB | |
| SCHEMBL4409632 | 0.68 | TK1 (0.44) | — | |
| SCHEMBL339966 | 0.68 | ALDH1A1 (0.41) | ALB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6653462-B2 | Useful as substrates for polymerases and in primer extension; mutants | APPLERA CORPORATION | 2003-11-25 | — | — | US | disclosed |
| US-20020151711-A1 | Nucleotide compounds including a rigid linker | PE CORPORATION (NY) (US) | 2002-10-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020151711-A1 | Nucleotide compounds including a rigid linker | TYMP, PNP, DCTD | ALB 3237/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.